Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06204549 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Assessment and Management of Comorbidities in Internal Medicine on Cardiovascular Risk

Study acronym: COMMEDCARDIO
StatusActive, Not Recruiting
PhaseNot applicable
Started2024-05-21
View on ClinicalTrials.gov ↗

Amendment history

2026-09-25
Enrollment closed, study ongoing
2025-09-24
Study Identification, Study Status, Oversight v3
Re-verified, no change to tracked fields
2025-05-13
Study Status v2
Primary completion date2026-05-21→2027-05-21
Completion date2026-11-21→2027-11-21
2024-06-03
Not Yet Recruiting→Recruiting Study Status, Conditions, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Primary completion date2024-04-15→2026-05-21
Completion date2025-01-15→2026-11-21
Start dateestimated 2024-01-15→confirmed 2024-05-21
Study sites0→1
2024-01-02
Original filing
The aim of assessing and managing cardiovascular risk is to avoid, limit or delay cardiovascular morbidity and mortality. Planned internal medicine hospitalization is developed around the management of cardiovascular risk in patients at high cardiovascular risk, whether in primary prevention or secondary prevention. During planned hospitalization, patients benefit from comprehensive, personalized and adapted care for their comorbidities and their CVRF (cardiovascular risk factors). This study will make it possible to evaluate this overall course of multidisciplinary management of comorbidities of patients at high cardiovascular risk.
Trial Details
NCT Number NCT06204549
Lead Sponsor University Hospital, Montpellier
Conditions Adverse Cardiac Event, Major Adverse Cardiac Events
Enrollment 70 participants
Start Date 2024-05-21
Primary Completion 2027-05-21 (estimated)
Study Completion 2027-11-21 (estimated)
Updated on ClinicalTrials.gov 2026-09-24